Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

5

Revenue 2017

Avastin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avastin was produced by Roche.

Roche reports positive phase 3 data for Tecentriq combination in liver cancer

Roche reports positive phase 3 data for Tecentriq combination in liver cancer

Safety for both Tecentriq and Avastin was reportedly consistent with the known safety profile of each medicine and with the underlying disease. ... With Tecentriq plus Avastin already a standard of care in unresectable HCC, we are pleased with the

Paris Court of Appeal overturns Novartis and Roche’s €444m anti-competitiveness fine

Paris Court of Appeal overturns Novartis and Roche’s €444m anti-competitiveness fine been ‘measured in tone’ in their comments about Avastin’s use in AMD. ... The court also ruled that Roche’s refusal to supply samples of Avastin for a comparator clinical trial could not have had an anti-competitive effect.

Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer

Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer Tecentriq in combination with Avastin significantly improved recurrence-free survival. Genentech – a member of the Roche group – has announced that its phase 3 study of Tecentriq (atezolizumab) combination mets its primary ... Safety for both

FDA approves ImmunoGen’s Elahere for platinum-resistant ovarian cancer

FDA approves ImmunoGen’s Elahere for platinum-resistant ovarian cancer of FRα and who had been treated with one to three prior systemic treatment regimens – at least one of which included Avastin (bevacizumab).

EC approves Celltrion Healthcare’s Vegzelma for multiple cancer types

EC approves Celltrion Healthcare’s Vegzelma for multiple cancer types The biosimilar to Genentech's Avastin was found to be highly similar to the reference product. ... Vegzelma is a recombinant humanised monoclonal antibody treatment biosimilar to Genentech's Avastin (bevacizumab), which is approved in the EU.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....